VICINI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.526
EU - Europa 2.105
AS - Asia 1.777
SA - Sud America 259
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 45
OC - Oceania 6
AN - Antartide 1
Totale 7.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.402
IT - Italia 825
SG - Singapore 527
CN - Cina 504
GB - Regno Unito 436
BR - Brasile 194
VN - Vietnam 169
HK - Hong Kong 166
SE - Svezia 155
IE - Irlanda 148
DE - Germania 130
BD - Bangladesh 110
FI - Finlandia 82
CA - Canada 67
RU - Federazione Russa 65
KR - Corea 62
FR - Francia 54
IN - India 51
ID - Indonesia 42
NL - Olanda 41
UA - Ucraina 38
MX - Messico 27
AR - Argentina 25
JP - Giappone 24
TR - Turchia 21
BG - Bulgaria 16
BE - Belgio 13
ES - Italia 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
CO - Colombia 12
MY - Malesia 12
PL - Polonia 12
ZA - Sudafrica 12
CR - Costa Rica 10
MK - Macedonia 10
PH - Filippine 10
PK - Pakistan 10
CL - Cile 9
IQ - Iraq 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
GR - Grecia 7
VE - Venezuela 7
AU - Australia 6
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
MA - Marocco 5
TH - Thailandia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
ET - Etiopia 4
JO - Giordania 4
NG - Nigeria 4
RS - Serbia 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
BH - Bahrain 2
BO - Bolivia 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
DK - Danimarca 1
EU - Europa 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MQ - Martinica 1
MZ - Mozambico 1
Totale 7.713
Salva come PNG Salva come JPEG
Città #
Ashburn 477
Singapore 360
Santa Clara 338
Southend 303
San Jose 230
Fairfield 184
Chandler 164
Hong Kong 163
Hefei 158
Dublin 140
Council Bluffs 134
Ann Arbor 103
Woodbridge 103
Beijing 92
Houston 82
Los Angeles 80
Seattle 79
Nyköping 77
Wilmington 70
Dearborn 62
Jacksonville 62
London 62
Milan 62
New York 60
Ho Chi Minh City 59
Bologna 58
Cambridge 57
Modena 57
Seoul 55
Helsinki 52
The Dalles 47
Hanoi 43
Chicago 39
Rome 39
Jakarta 36
Munich 31
Shanghai 30
Boardman 29
Reggio Emilia 27
San Diego 26
São Paulo 25
Dallas 22
Toronto 21
Lauterbourg 19
Bremen 18
Orem 18
Tokyo 18
Buffalo 17
Newark 17
Turin 17
Eugene 16
Frankfurt am Main 16
Moscow 16
Princeton 16
Sofia 16
Turku 16
Bari 15
Columbus 14
Florence 14
Brussels 12
Denver 12
Parma 12
Mexico City 11
Palermo 11
Redwood City 11
Amsterdam 10
Hillsboro 10
Nuremberg 10
Salt Lake City 10
Warsaw 10
Brooklyn 9
Izmir 9
Kent 9
Lappeenranta 9
Montreal 9
Redondo Beach 9
Atlanta 8
Falls Church 8
Haiphong 8
Las Vegas 8
Phoenix 8
Belo Horizonte 7
Boston 7
Chennai 7
Poplar 7
San José 7
Tampa 7
Vancouver 7
Washington 7
Brasília 6
Buenos Aires 6
Chengdu 6
Ferrara 6
Fulham 6
Kuala Lumpur 6
Monterrey 6
Paris 6
Stockholm 6
Brescia 5
Catania 5
Totale 4.994
Salva come PNG Salva come JPEG
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 528
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 512
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 434
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 428
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 413
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 373
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 361
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 330
Biomarker expression and survival after primary chemotherapy for breast cancer. 329
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 309
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 295
Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial 290
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 286
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study 283
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 272
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 269
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 252
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 234
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 226
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 220
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 219
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 216
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 189
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 187
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 167
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 156
Totale 7.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 0 0 0 12 10 26 16 31 51 23 103 43
2022/2023651 53 61 40 46 57 62 16 50 195 12 27 32
2023/2024577 31 26 33 57 54 54 63 73 36 46 51 53
2024/20251.426 37 25 45 110 254 230 101 78 155 51 129 211
2025/20262.608 216 103 191 284 389 128 337 110 219 293 229 109
2026/2027744 94 159 193 298 0 0 0 0 0 0 0 0
Totale 7.778